Search Results 2051-2060 of 16575 for Dupuytren's contracture

  1. Minimally invasive surgery - Doctors & Departments - Mayo Clinic

    ... disease, Heart valve disease, Heart arrhythmia, Pericardial disease. Show more areas of focus for Arman Arghami, M.D., M.P.H.. Samir ...

  2. Pediatrics Clinical Trials - Medical Professionals

    Rochester, Minn. The purpose of this study is to derive and characterize patient-specific disease models for sudden death-predisposing heritable channelopathies ...

  3. Pediatrics Clinical Trials - Medical Professionals

    The purpose of this study is to derive and characterize patient-specific disease models for sudden death-predisposing heritable channelopathies and ...

  4. Pediatrics Clinical Trials - Medical Professionals

    Rochester, Minn. The purpose of this study is to derive and characterize patient-specific disease models for sudden death-predisposing heritable channelopathies ...

  5. Publications - Steven Bowers, M.D. - Mayo Clinic

    ... Disease Control, and Survival Outcomes. Int J Part Ther. 2023 Winter; 9 (3):18-29 Epub 2022 Dec 19. View PubMed; Gunturu NS, Castillo-Larios R, Bowers S ...

  6. Venous Malformation Clinical Trials - Mayo Clinic Research

    Florida Cerebrovascular Disease Biorepository and Genomics Center Jacksonville, FL ... disease, fibrosmuscular dysplasia (FMD), non-traumatic, angiography- ...

  7. Publications - Nandan S. Anavekar, M.B., B.Ch. - Mayo Clinic

    Intravascular Ultrasound during Endovascular Intervention for Peripheral Artery Disease, by Severity, Location, Device, and Procedure. Am J Cardiol. 2024 ...

  8. Overview - Human Integrative and Environmental Physiology Lab: Bruce D. Johnson - Mayo Clinic Research

    The Human Integrative and Environmental Physiology Laboratory, led by principal investigator Bruce D. Johnson, Ph.D., researches human health and disease in ...

  9. Midostaurin and Decitabine in Treating Older Patients With Newly Diagnosed Acute Myeloid Leukemia and FLT3 Mutation - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...

  10. A Study to Evaluate the Effectiveness and Safety of Camidanlumab Tesirine (ADCT-301) in Patients with Relapsed or Refractory Hodgkin Lymphoma - Mayo Clinic

    Participation eligibility. Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines ...